Overview

A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This open-label, 2-period, fixed sequence, drug interaction study will investigate the effect of co-administration of itraconazole on the pharmacokinetics of cobimetinib in healthy participants. Participants will receive multiple repeating doses of cobimetinib and itraconazole.
Phase:
Phase 1
Details
Lead Sponsor:
Genentech, Inc.
Treatments:
Hydroxyitraconazole
Itraconazole